ORIGINAL ARTICLE

How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma

G S Mijnhout¹, O S Hoekstra¹, A van Lingen¹, P J van Diest², H J Adèr⁴, A A Lammertsma¹, R Pijpers¹, S Meijer³ and G J J Teule¹

¹ Department of Nuclear Medicine, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
² Department of Pathology, VU University Medical Center
³ Department of Surgical Oncology, VU University Medical Center
⁴ Clinical Epidemiology and Biostatistics, VU University Medical Center

Correspondence to:
Correspondence to:
Dr G S Mijnhout, Department of Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands;
gs.mijnhout{at}vumc.nl

Background: In primary cutaneous melanoma, the sentinel node (SN) biopsy is an accurate method for the staging of the lymph nodes. Positron emission tomography (PET) has been suggested as a useful alternative. However, the sensitivity of PET may be too low to detect SN metastases, which are often small.

Aim: To predict the value of PET for initial lymph node staging in melanoma based on morphometric analysis of SN metastatic load, without exposing patients to PET.

Material and methods: In 59 SN positive patients with melanoma, the sizes of tumour deposits in the SNs and subsequent dissection specimens were measured by morphometry and correlated with the detection limits of current and future PET scanners.

Results: The median tumour volume within the basin was 0.15 mm³ (range, 0.0001–118.86). Seventy per cent of these deposits were smaller than 1 mm³. State of the art PET scanners that have a resolution of about 5 mm would detect only 15–49% of positive basins. Logistic regression analysis revealed no pretest indicators identifying patients expected to have a positive PET. However, the SN tumour load was a significant and single predictor of the presence of PET detectable residual tumour.

Conclusion: Morphometric analysis of metastatic load predicts that PET scanning is unable to detect most metastatic deposits in sentinel lymph nodes of patients with melanoma because the metastases are often small. Therefore, the SN biopsy remains the preferred method for initial regional staging.

Keywords: positron emission tomography; ¹⁸F-fluorodeoxyglucose; melanoma; staging; lymph nodes; sentinel node

Abbreviations: FDG, ¹⁸F-fluorodeoxyglucose; H&E, haematoxylin and eosin; LN, locoregional lymph node; LND, lymph node dissection; PET, positron emission tomography; SN, sentinel node

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Pawlik, T. M., Erasmus, J. J., Truong, M. T., Macapinlac, H., Ross, M. I., Gershenwald, J. E. (2006). Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma.. Am. J. Roentgenol. 187: W117-W119 [Full Text]  
• Aloia, T. A., Gershenwald, J. E., Andtbacka, R. H., Johnson, M. M., Schacherer, C. W., Ng, C. S., Cormier, J. N., Lee, J. E., Ross, M. I., Mansfield, P. F. (2006). Utility of Computed Tomography and Magnetic Resonance Imaging Staging Before Completion Lymphadenectomy in Patients With Sentinel Lymph Node-Positive Melanoma. JCO 24: 2858-2865 [Abstract] [Full Text]  
• Belhocine, T. Z., Scott, A. M., Even-Sapir, E., Urbain, J.-L., Essner, R. (2006). Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma. JNM 47: 957-967 [Abstract] [Full Text]  
• Clark, P. B., Soo, V., Kraas, J., Shen, P., Levine, E. A. (2006). Futility of fluorodeoxyglucose f 18 positron emission tomography in initial evaluation of patients with t2 to t4 melanoma.. Arch Surg 141: 284-288 [Abstract] [Full Text]  
• Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., Cheson, B. D., O'Shaughnessy, J., Guyton, K. Z., Mankoff, D. A., Shankar, L., Larson, S. M., Sigman, C. C., Schilsky, R. L., Sullivan, D. C. (2005). Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development. Clin. Cancer Res. 11: 2785-2808 [Abstract] [Full Text]  
• Fuster, D., Chiang, S., Johnson, G., Schuchter, L. M., Zhuang, H., Alavi, A. (2004). Is 18F-FDG PET More Accurate Than Standard Diagnostic Procedures in the Detection of Suspected Recurrent Melanoma?. JNM 45: 1323-1327 [Abstract] [Full Text]  
• Cobben, D. C.P., Jager, P. L., Elsinga, P. H., Maas, B., Suurmeijer, A. J.H., Hoekstra, H. J. (2003). 3'-18F-Fluoro-3'-Deoxy-L-Thymidine: A New Tracer for Staging Metastatic Melanoma?. JNM 44: 1927-1932 [Abstract] [Full Text]  

eLetters:

Read all eLetters

From scientific approach to technical details

Tarik Belhocine

JCP Online, 5 Jun 2003 [Full text]

Author's Reply

G.S. Mijnhout, et al.

JCP Online, 26 Jun 2003 [Full text]

Resolution

Lodewijk Cobben

JCP Online, 7 Oct 2003 [Full text]